SJ
Sunaina Jain
About Sunaina Jain
Data last updated:
Sunaina Jain is a Director at Nordea Lifescience Private Limited (since 2008) and Director at Orange Pharma Private Limited (since 2009). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹2.38 Cr; the largest is Nordea Lifescience Private Limited at ₹2.38 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Aug 2008 | 2004 | ₹2.38 Cr (FY 2025) | Active | |
| Director | 25 Aug 2009 | 2004 | ₹7,100 (FY 2025) | Active |
Board colleagues of Sunaina Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kuldeep Jain | 00092156 | Nordea Lifescience Private Limited , Orange Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunaina Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunaina Jain
Sunaina Jain currently holds 2 directorships: Nordea Lifescience Private Limited (Director, since 11 Aug 2008, revenue ₹2.38 Cr (FY 2025)); Orange Pharma Private Limited (Director, since 25 Aug 2009, revenue ₹7,100 (FY 2025)).
Sunaina Jain was first appointed on 11 Aug 2008 as Director at Nordea Lifescience Private Limited. The most recent appointment on record is 25 Aug 2009 at Orange Pharma Private Limited.
The 2 current companies of Sunaina Jain that report revenue have a combined latest revenue of ₹2.38 Cr: Nordea Lifescience Private Limited ₹2.38 Cr (FY 2025); Orange Pharma Private Limited ₹7,100 (FY 2025).
The current boards of Sunaina Jain's companies include Kuldeep Jain (Nordea Lifescience Private Limited).